| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Onconova Therapeutics Inc | 520,832 | 1,453,000 | 78.80% | ||
| 2 | ONCONOVA THERAPEUTICS INC | 390,624 | 391,000 | 21.20% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000905718-16-001753, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.